Authors: VITOLO U GAIDANO G BOTTO B VOLPE G AUDISIO E BERTINI M CALVI R FREILONE R NOVERO D ORSUCCI L PASTORE C CAPELLO D PARVIS G SACCO C ZAGONEL V CARBONE A MAZZA U PALESTRO G SAGLIO G RESEGOTTI L

Citation: U. Vitolo et al., REARRANGEMENTS OF BCL-6, BCL-2, C-MYC AND 6Q DELETION IN B-DIFFUSE LARGE-CELL LYMPHOMA - CLINICAL RELEVANCE IN 71 PATIENTS, Annals of oncology, 9(1), 1998, pp. 55-61

Authors: BERTINI M RUS C FREILONE R BOTTO B CALVI R NOVERO D ORSUCCI L VITOLO U PALESTRO G RESEGOTTI L

Citation: M. Bertini et al., MANTLE CELL LYMPHOMA - A RETROSPECTIVE STUDY ON 27 PATIENTS - CLINICAL-FEATURES AND NATURAL-HISTORY, Haematologica, 83(4), 1998, pp. 312-316

Authors: BERTINI M FREILONE R BOTTO B CALVI R GALLAMINI A GATTI AM LIBERATI AM MENEGHINI V ORLANDI E ORSUCCI L PIZZUTI M SCALABRINI DR SALVI F TODESCHINI G VITOLO U RESEGOTTI L

Citation: M. Bertini et al., IDARUBICIN IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMAS - A RANDOMIZED TRIAL COMPARING VACOP-B (A=DOXORUBICIN) VS VICOP-B (I=IDARUBICIN), Haematologica, 82(3), 1997, pp. 309-313

Authors: VITOLO U BOTTO B BOCCOMINI C CALVI R BERTINI M VASINO MAC FREILONE R LEVIS A ORSUCCI L RESEGOTTI L

Citation: U. Vitolo et al., INTENSIFIED CHEMOTHERAPHY WITH DOSE INTENSITY ESCALATION OF CYCLOFOSPHAMIDE AND EPIRUBICINE WITH FILGRASTIM SUPPORT (MEGACEOP) FOR POOR-PROGNOSIS AGGRESSIVE NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 838-838

Authors: FREILONE R BOTTO B VITOLO U BERTINI M AUDISIO E CALVI R CUCCHI M DECRESCENZO A GALLAMINI A GHIO R GRISO L LEVIS A MASSARA G ORSUCCI L RICARDI U SCALABRINI DR SALVI F SECONDO V RESEGOTTI L

Citation: R. Freilone et al., COMBINED-MODALITY TREATMENT WITH A WEEKLY BRIEF CHEMOTHERAPY (ACOP-B)FOLLOWED BY LOCOREGIONAL RADIOTHERAPY IN LOCALIZED-STAGE INTERMEDIATE-GRADE TO HIGH-GRADE NON-HODGKINS-LYMPHOMA, Annals of oncology, 7(9), 1996, pp. 919-924